[Federal Register Volume 76, Number 244 (Tuesday, December 20, 2011)]
[Notices]
[Pages 78931-78933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-32469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]


Advisory Committees; Tentative Schedule of Meetings for 2012

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a

[[Page 78932]]

tentative schedule of forthcoming meetings of its public advisory 
committees for 2012. During 1991, at the request of the Commissioner of 
Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) 
conducted a study of the use of FDA's advisory committees. In its final 
report, one of the IOM's recommendations was for the Agency to publish 
an annual tentative schedule of its meetings in the Federal Register. 
This publication implements the IOM's recommendation.

FOR FURTHER INFORMATION CONTACT: Teresa L. Hays, Advisory Committee 
Oversight and Management Staff, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 32, Rm. 5290, Silver Spring, MD 20993, (301) 796-
8220.

SUPPLEMENTARY INFORMATION: The IOM, at the request of the Commissioner, 
undertook a study of the use of FDA's advisory committees. In its final 
report in 1992, one of the IOM's recommendations was for FDA to adopt a 
policy of publishing an advance yearly schedule of its upcoming public 
advisory committee meetings in the Federal Register; FDA has 
implemented this recommendation. The annual publication of tentatively 
scheduled advisory committee meetings will provide both advisory 
committee members and the public with the opportunity, in advance, to 
schedule attendance at FDA's upcoming advisory committee meetings. 
Because the schedule is tentative, amendments to this notice will not 
be published in the Federal Register. However, changes to the schedule 
will be posted on the FDA advisory committees' Internet site located at 
http://www.fda.gov/AdvisoryCommittees/default.htm. FDA will continue to 
publish a Federal Register notice 15 days in advance of each upcoming 
advisory committee meeting, to announce the meeting (21 CFR 14.20).
    The following list announces FDA's tentatively scheduled advisory 
committee meetings for 2012.

                                 Table 1
------------------------------------------------------------------------
             Committee name              Tentative date(s) of meeting(s)
------------------------------------------------------------------------
                       OFFICE OF THE COMMISSIONER
------------------------------------------------------------------------
Pediatric Advisory Committee...........  January 30-31, May & December
                                          date(s), if needed, to be
                                          determined.
Risk Communication Advisory Committee..  February 13-14, April 30, May
                                          1, August 16-17, November 1-2.
Science Board to FDA...................  January 6, May 2, October 3.
------------------------------------------------------------------------
              CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
------------------------------------------------------------------------
Allergenic Products Advisory Committee.  April 18, October 18.
Blood Products Advisory Committee......  February 28-29, May 15-16, July
                                          31-August 1, December 4-5.
Cellular, Tissue and Gene Therapies      February 9-10, June 27-28,
 Advisory Committee.                      November 29-30.
Transmissible Spongiform                 Date(s), if needed, to be
 Encephalopathies Advisory Committee.     determined.
Vaccines and Related Biological          February 28-29, May 16-17,
 Products Advisory Committee.             September 19-20, November 14-
                                          15.
------------------------------------------------------------------------
                 CENTER FOR DRUG EVALUATION AND RESEARCH
------------------------------------------------------------------------
Anesthetic and Analgesic Drugs Advisory  February 9.
 Committee (formerly the Anesthetic and
 Life Support Drugs Advisory Committee).
Anti-Infective Drugs Advisory Committee  Date(s), if needed, to be
                                          determined.
Antiviral Drugs Advisory Committee.....  May 16-17.
Arthritis Advisory Committee...........  March 12.
Cardiovascular and Renal Drugs Advisory  February 23.
 Committee.
Dermatologic and Ophthalmic Drugs        February 27.
 Advisory Committee.
Drug Safety and Risk Management          Date(s), if needed, to be
 Advisory Committee.                      determined.
Endocrinologic and Metabolic Drugs       February 22, March 28-29.
 Advisory Committee.
Gastrointestinal Drugs Advisory          March 13-14.
 Committee.
Medical Imaging Drugs Advisory           Date(s), if needed, to be
 Committee.                               determined.
Nonprescription Drugs Advisory           Date(s), if needed, to be
 Committee.                               determined.
Oncologic Drugs Advisory Committee.....  February 8-9, March 20-21, June
                                          20-21, July 24-25, September
                                          12-13, November 6-7, December
                                          4-5.
Peripheral and Central Nervous System    Date(s), if needed, to be
 Drugs Advisory Committee.                determined.
Advisory Committee for Pharmaceutical    March 14.
 Science and Clinical Pharmacology.
Psychopharmacologic Drugs Advisory       Date(s), if needed, to be
 Committee.                               determined.
Pulmonary-Allergy Drugs Advisory         February 23-24.
 Committee.
Advisory Committee for Reproductive      January 20, April 5.
 Health Drugs.
------------------------------------------------------------------------
               CENTER FOR DEVICES AND RADIOLOGICAL HEALTH
------------------------------------------------------------------------
       Medical Devices Advisory Committee (Comprised of 18 Panels)
------------------------------------------------------------------------
Device Good Manufacturing Practices      Date(s), if needed, to be
 Advisory Committee.                      determined.
Anesthesiology and Respiratory Therapy   June 8, November 16.
 Devices Panel.
Circulatory System Devices Panel.......  Date(s), if needed, to be
                                          determined.
Clinical Chemistry and Clinical          April 20, July 18-19, September
 Toxicology Devices Panel.                20-21.
Dental Products Panel..................  Date(s), if needed, to be
                                          determined.
Ear, Nose, and Throat Devices Panel....  Date(s), if needed, to be
                                          determined.
Gastroenterology-Urology Devices Panel.  July 13.
General and Plastic Surgery Devices      July 17.
 Panel.
General Hospital and Personal Use        August 16-17.
 Devices Panel.
Hematology and Pathology Devices Panel.  June 28.
Immunology Devices Panel...............  Date(s), if needed, to be
                                          determined.

[[Page 78933]]

 
Medical Devices Dispute Resolution       Date(s), if needed, to be
 Panel.                                   determined.
Microbiology Devices Panel.............  Date(s), if needed, to be
                                          determined.
Molecular and Clinical Genetics Panel..  June 27.
Neurological Devices Panel.............  Date(s), if needed, to be
                                          determined.
Obstetrics and Gynecology Devices Panel  July 5-6.
Ophthalmic Devices Panel...............  November 8-9.
Orthopedic and Rehabilitation Devices    September 13-14, November 16,
 Panel.                                   December 6-7.
Radiological Devices Panel.............  November 2.
National Mammography Quality Assurance   October 18.
 Advisory Committee.
Technical Electronic Product Radiation   June 14.
 Safety Standards Committee.
------------------------------------------------------------------------
              CENTER FOR FOOD SAFETY AND APPLIED NUTRITION
------------------------------------------------------------------------
Food Advisory Committee................  December 13-14.
------------------------------------------------------------------------
                       CENTER FOR TOBACCO PRODUCTS
------------------------------------------------------------------------
Tobacco Products Scientific Advisory     January 18-20, March 1-2.
 Committee.
------------------------------------------------------------------------
                     CENTER FOR VETERINARY MEDICINE
------------------------------------------------------------------------
Veterinary Medicine Advisory Committee.  Date(s), if needed, to be
                                          determined.
------------------------------------------------------------------------
            NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR)
------------------------------------------------------------------------
Science Advisory Board to NCTR.........  October 23-24.
------------------------------------------------------------------------


    Dated: December 14, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-32469 Filed 12-19-11; 8:45 am]
BILLING CODE 4160-01-P